Literature DB >> 2666144

Pgp-1hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A.

A Lerner1, T Yamada, R A Miller.   

Abstract

Aging is associated with an accumulation of T cells functionally hyporesponsive to the effects of mitogens such as concanavalin A. Recent studies in mice and human have identified surface markers useful for distinguishing antigen-stimulated memory T cells from virgin T cells. In mice, memory T cells within the CD8+ cell population have been shown to express relatively high levels of the cell surface glycoprotein Pgp-1. On the theory that aging might diminish the supply of virgin thymic emigrants without compromising the production of memory T cells, we examined the proportion of Pgp-1hiCD4+ and CD8+ cells in the spleen, blood and lymph nodes of mice of varying age. We found a dramatic (2.5-fold) age-associated increase in the percentage of cells with the Pgp-1hi phenotype. By limiting dilution methods, the frequency of concanavalin A-responsive T cells was found to be significantly reduced in the Pgp-1hi cell pool, whether measured by interleukin 2-dependent proliferation, interleukin 2 production or generation of cytotoxic effectors. Pgp-1hi and Pgp-1lo T cells from young mice proliferate equally well when stimulated by optimal doses of phorbol myristate acetate and ionomycin suggesting that the poor responses to concanavalin A do not simply reflect low viability. Aging leads both to an increase in mitogen-hyporesponsive Pgp-1hi T cells, and also to lower responsiveness of cells in the Pgp-1hi subset.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666144     DOI: 10.1002/eji.1830190604

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  65 in total

Review 1.  The immune system in the elderly: II. Specific cellular immunity.

Authors:  L Ginaldi; M De Martinis; A D'Ostilio; L Marini; M F Loreto; V Martorelli; D Quaglino
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  The immune system in the elderly: III. Innate immunity.

Authors:  L Ginaldi; M De Martinis; A D'Ostilio; L Marini; M F Loreto; D Quaglino
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  Variation of bronchoalveolar lymphocyte phenotypes with age in the physiologically normal human lung.

Authors:  K C Meyer; P Soergel
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

4.  Proliferative responses of blood mononuclear cells (BMNC) in a cohort of elderly humans: role of lymphocyte phenotype and cytokine production.

Authors:  H Bruunsgaard; A N Pedersen; M Schroll; P Skinhøj; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 5.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

6.  Effects of aging on the adaptive immune response to respiratory virus infections.

Authors:  Ross B Fulton; Steven M Varga
Journal:  Aging health       Date:  2009-12-01

Review 7.  Homeostasis and the age-associated defect of CD4 T cells.

Authors:  Susan Swain; Karen Clise-Dwyer; Laura Haynes
Journal:  Semin Immunol       Date:  2005-10       Impact factor: 11.130

Review 8.  The effect of aging on cognate function and development of immune memory.

Authors:  Laura Haynes
Journal:  Curr Opin Immunol       Date:  2005-10       Impact factor: 7.486

9.  An eight-colour flow cytometric method for the detection of reference values of lymphocyte subsets in selected healthy donors.

Authors:  Bianca Rovati; Sara Mariucci; Rossella Poma; Carmine Tinelli; Sara Delfanti; Paolo Pedrazzoli
Journal:  Clin Exp Med       Date:  2013-05-28       Impact factor: 3.984

10.  Decreased resistance to primary intravenous Cryptococcus neoformans infection in aged mice despite adequate resistance to intravenous rechallenge.

Authors:  K M Aguirre; G W Gibson; L L Johnson
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.